SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-102826
Filing Date
2021-08-10
Accepted
2021-08-10 16:02:04
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20210630x10q.htm   iXBRL 10-Q 1228403
2 EXHIBIT 31.1 mrkr-20210630xex31d1.htm EX-31.1 15083
3 EXHIBIT 31.2 mrkr-20210630xex31d2.htm EX-31.2 15075
4 EXHIBIT 32.1 mrkr-20210630xex32d1.htm EX-32.1 7497
5 EXHIBIT 32.2 mrkr-20210630xex32d2.htm EX-32.2 8101
11 GRAPHIC mrkr-20210630x10q001.jpg GRAPHIC 6534
12 GRAPHIC mrkr-20210630x10q002.jpg GRAPHIC 19268
  Complete submission text file 0001104659-21-102826.txt   4716309

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20210630_lab.xml EX-101.LAB 262281
7 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20210630.xsd EX-101.SCH 35497
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20210630_pre.xml EX-101.PRE 210174
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrkr-20210630_cal.xml EX-101.CAL 35829
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20210630_def.xml EX-101.DEF 78021
13 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20210630x10q_htm.xml XML 810410
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 211159816
SIC: 2834 Pharmaceutical Preparations